Accreditation in Interventional Radiology: Why it Matters and Why we Sought IASIOS Certification

Tashi, Sonam; Chandramohan, Sivanathan; Adam, Andreas; Tan, Bien Soo

doi:10.1007/s00270-022-03201-3

Cited by 5 publications

(3 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…demonstrated that the median overall survival of HCC patients treated with TACE increased from 21.35 months in 2002 (based on two studies published that year) to 36.15 months in 2018 (based on four studies published that year). Efforts to standardise care in IO are therefore vital 74–77 …”

Section: Discussionmentioning

confidence: 99%

Research in interventional oncology: How sound is the evidence base?

2023

View full text Add to dashboard Cite

IntroductionInterventional oncology (IO) is an essential component of cancer care, which has gained substantial recognition in recent years. The aim of this review is to evaluate the level of evidence supporting IO and its inclusion in cancer treatment guidelines.MethodsA literature search of the PubMed database was performed to identify publication numbers and types for IO treatments published between 2012 and 2022. Selected cancer treatment guidelines and recommendations were reviewed for their inclusion of IO treatments.ResultsWith 68%, the majority of studies on IO treatments are case reports while randomised controlled trials (RCTs) amount only to 7% of studies. Despite this, IO studies have generated sufficient data to support the inclusion of IO treatments in cancer treatment guidelines and recommendations. This was frequently based on large prospective patient cohorts that corresponded to 24% (20% non‐randomised studies and 4% observational studies) of all analysed studies rather than RCTs.ConclusionThe level of evidence underpinning IO, as well as inclusion of IO in treatment guidelines and recommendations have increased substantially in recent years, indicating the growing importance and acceptance of IO in cancer care. The difficulty in conducting RCTs in IO is mitigated by the observation that they are not necessary to achieve guideline‐inclusion. Nevertheless, it is crucial to conduct well‐designed research projects to further consolidate the position of IO in the field of oncology. This will ensure that IO continues to evolve and meet the needs of cancer patients worldwide.

show abstract

Section: Discussionmentioning

confidence: 99%

Research in interventional oncology: How sound is the evidence base?

2023

View full text Add to dashboard Cite

show abstract

“…Currently, there are IASIOS-accredited centers in Europe, Asia, and Australia, and the numbers are increasing. According to a recent editorial manuscript from an IASIOS-accredited center, the framework of IASIOS may also offer benefits when expanded to the rest of the IR service [ 17 ]. We agree with the above conclusion of the authors, as there is still no national, regional, or internationally recognized accreditation system for IR.…”

Section: Discussionmentioning

confidence: 99%

Compliance of Interventional Radiologists With Interventional Oncology Accreditation Standards

Dokdok¹,

Balli²

2023

Cureus

View full text Add to dashboard Cite

Purpose: We aimed to evaluate interventional radiologists' compliance with patient care and the quality management process of cancer patients using a national survey.Methods: An electronic survey was designed with questions derived from the core criteria of the International Accreditation System for Interventional Oncology (IASIOS), with the approval of the IASIOS council. Among the interventional radiologists contacted by e-mail through the national association, 34 responded to the questionnaire. The agreement of the participants with the core requirements was evaluated in five questions consisting of 34 articles using the 5-point Likert scale.Results: Regarding the years of experience in interventional radiology (IR), the mean scale for the less than five-year group was 118.4, while that for the group with more than 15 years was 145.17 (p = 0.030). The mean scale of the five-to 15-year-old group was 121.75, versus that of more than 15 years, which was 145.17 (p = 0.028). Thus, significant differences arose between 15 years and five to 15 years versus >15 years groups; later groups were more likely to comply. There was also a statistical difference between the groups formed according to the ratio of oncological interventions (<25% vs. 25%-50%) in the daily workload (p = 0.010).Conclusion: Increased experience in IR and more relay on oncological interventions appear to augment compliance with the IASIOS criteria. We believe that interventional radiologists who have distinct territorial praxis could benefit from such a framework with improved self-awareness.

show abstract

“…The focus of the journals on studies related to liver ablation can assist scientists in selecting suitable publications for their research on the subject and enable readers to identify journals Author's keywords A worth following. JVIR [25], Radiology [26], and CVIR [27], 3 out of 108 radiology-related journals, are notable for their particular interest in studies on liver ablation, with JVIR ranking first in the total number of published articles [25].…”

Section: Database Analysismentioning

confidence: 99%

Bibliometric Analysis of the Literature Concerning Anesthesia in Liver Tumor Ablation Published in the Web of Science Core Collection (WoSCC) Database from 1999 to 2022

Qu¹,

Chen²,

Li³

2023

Med Sci Monit

View full text Add to dashboard Cite

Background:Ablation has been developed as a radical surgical procedure for liver tumors. Local anesthesia in combination with general anesthesia or intravenous sedation is needed in ablative procedures. Although many studies have been published, a related bibliometric study is lacking. The present bibliometric analysis aimed to further understand the current situation of anesthesia for liver tumor ablation and discover candidate novel research directions. Material/Methods:Web of Science Core Collection (WoSCC) was searched to identify studies associated with anesthesia for liver tumor ablation. Also, countries, journals, authors, and institutes contribution together with co-occurrence relations were analyzed by R, VOSviewer, and CiteSpace software; meanwhile, relevant research hotspots together with potential future trends were identified. Results:This work obtained 183 English-language documents during 1999-2022, and the annual growth rate was 8.83%. Most studies were conducted in the United States (24.04%, 44/183). The Oslo Univ Hosp contributed the most publications (n=11, 6.01%). Livraghi T (n=6), De Baere T (n=5), and Goldberg SN (n=4) ranked top in terms of cited authors and top authors. Keywords from that co-cited network were aggregated and identified, which revealed a shift in the liver tumor ablation anesthesia field. Initially, hotspots were predominantly "alcohol injection", "radiofrequency tissue ablation", and "metastases", but hotspots shifted to "efficacy", "ablation", "pain", "microwave ablation", "management", "analgesia", "safety", "irreversible electroporation", and "anesthesia" recently. Conclusions:Anesthesia has received increased attention as liver tumor ablation advances. Bibliometric study findings provide insight into the current state and trends of anesthesia in liver tumor ablation research.

show abstract

Accreditation in Interventional Radiology: Why it Matters and Why we Sought IASIOS Certification

Cited by 5 publications

References 5 publications

Research in interventional oncology: How sound is the evidence base?

Research in interventional oncology: How sound is the evidence base?

Compliance of Interventional Radiologists With Interventional Oncology Accreditation Standards

Bibliometric Analysis of the Literature Concerning Anesthesia in Liver Tumor Ablation Published in the Web of Science Core Collection (WoSCC) Database from 1999 to 2022

Contact Info

Product

Resources

About